Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | iloprost | 5311181 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | iloprost | 5311181 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | iloprost | 5311181 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | iloprost | 5311181 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | trifluoperazine | 5566 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | trifluoperazine | 5566 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | trifluoperazine | 5566 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | trifluoperazine | 5566 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | trifluoperazine | 5566 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | trifluoperazine | 5566 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | trifluoperazine | 5566 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | trifluoperazine | 5566 | drug-path |
| Glioma | Q9NZM4 | map05214 | trifluoperazine | 5566 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | trifluoperazine | 5566 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | trifluoperazine | 5566 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | trifluoperazine | 5566 | drug-path |
| Basal transcription factors | R-HSA-3232118 | map03022 | trifluoperazine | 5566 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | trifluoperazine | 5566 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | trifluoperazine | 5566 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | chlorpromazine | 2726 | drug-path |